Technology areas: Biotechnology & Pharmaceuticals • Networking & Security • Transportation, E-Commerce & Mechanical Systems • Medical Devices & Mechanical Engineering
9 pending office actions • 7 clients • 8 examiners • 8 art units • 0 of 9 (0%) have an AI response strategy ready • 19 patents granted in the last 365 days
Gardella Alciati has 9 pending office actions in Biotechnology & Pharmaceuticals and 404 career applications. The profile records current prosecution activity alongside a defined historical application volume.
The resolved allowance rate is 89.8%, and the average is 2.44 office actions per allowance. The allowance measure describes resolved outcomes, while the action average indicates the recorded interaction needed for allowances.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (11%) |
| §101 + other | 4 (44%) |
| §103 only | 2 (22%) |
| Double-patenting + other | 1 (11%) |
| Multi-statute (no §101) | 1 (11%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAYMONDA, MATTHEW HAROLD | 2 | 40.0% | +47.7% |
| POLLACK, MELVIN H | 1 | 86.0% | +5.0% |
| PATEL, PARTHKUMAR | 1 | 78.3% | +23.1% |
| DANG, CHRISTINE | 1 | 49.7% | +51.4% |
| EGLOFF, PETER RICHARD | 1 | 43.4% | +31.8% |
| OUSPENSKI, ILIA I | 1 | 77.3% | +20.6% |
| ZINK, AMANDA L | 1 | 85.2% | +3.1% |
| LEVINE, ADAM L | 1 | 35.9% | +40.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19337268 | SYSTEM AND METHOD FOR A GLOBAL VIRTUAL NETWORK | POLLACK, MELVIN H | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18754026 | Automated Evaluation of Free-Form Answers and Generation of Actionable Feedback to Multidimensional Reasoning Questions | EGLOFF, PETER RICHARD | 23d overdue |
| 19041739 | DATA MANAGEMENT SYSTEMS AND METHODS FOR ASSET TOKENIZATION, BLOCKCHAIN-BASED VERIFICATION, AND INTRINSIC VALUATION | DANG, CHRISTINE | — |
| 18423075 | METHODS FOR IDENTIFYING PROTEIN CODING SEQUENCES USING DNA BARCODES | RAYMONDA, MATTHEW HAROLD | — |
| 18291791 | METHODS FOR IDENTIFYING PROTEIN CODING SEQUENCES USING DNA BARCODES | RAYMONDA, MATTHEW HAROLD | — |
| 18374601 | Treatment of Kidney Disease Using Renal Nerve Denervation Via the Renal Pelvis | ZINK, AMANDA L | — |
| 18143482 | SYSTEMS AND METHODS FOR PROVIDING RECOMMENDATIONS BASED ON COLLABORATIVE AND/OR CONTENT-BASED NODAL INTERRELATIONSHIPS | LEVINE, ADAM L | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18754026 | Automated Evaluation of Free-Form Answers and Generation of Actionable Feedback to Multidimensional Reasoning Questions | EGLOFF, PETER RICHARD | 23d overdue |
| 19307119 | SYSTEM AND METHOD FOR VIRTUAL INTERFACES AND ADVANCED SMART ROUTING IN A GLOBAL VIRTUAL NETWORK | PATEL, PARTHKUMAR | 35d |
| 19041739 | DATA MANAGEMENT SYSTEMS AND METHODS FOR ASSET TOKENIZATION, BLOCKCHAIN-BASED VERIFICATION, AND INTRINSIC VALUATION | DANG, CHRISTINE | — |
| 18423075 | METHODS FOR IDENTIFYING PROTEIN CODING SEQUENCES USING DNA BARCODES | RAYMONDA, MATTHEW HAROLD | — |
| 18291791 | METHODS FOR IDENTIFYING PROTEIN CODING SEQUENCES USING DNA BARCODES | RAYMONDA, MATTHEW HAROLD | — |
| 18535960 | Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS | OUSPENSKI, ILIA I | — |
| 18143482 | SYSTEMS AND METHODS FOR PROVIDING RECOMMENDATIONS BASED ON COLLABORATIVE AND/OR CONTENT-BASED NODAL INTERRELATIONSHIPS | LEVINE, ADAM L | — |
| Client (Assignee) | Pending OAs |
|---|---|
| UMBRA Technologies Ltd. | 2 |
| A-Alpha Bio, Inc. | 2 |
| STEEL American Luxury, LLC | 1 |
| BrainPOP | 1 |
| Weizmann Institute of Science | 1 |
| Verve Medical, Inc. | 1 |
| Nara Logics, Inc. | 1 |
| Art Unit | Apps |
|---|---|
| 1684 | 2 |
| 2445 | 1 |
| 2479 | 1 |
| 3698 | 1 |
| 3715 | 1 |
| 1644 | 1 |
| 3794 | 1 |
| 3689 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19337268 | SYSTEM AND METHOD FOR A GLOBAL VIRTUAL NETWORK | UMBRA Technologies Ltd. | POLLACK, MELVIN H | 2445 | §103 | Non-Final OA | — | Pending | Sep 23, 2025 |
| 19307119 | SYSTEM AND METHOD FOR VIRTUAL INTERFACES AND ADVANCED SMART ROUTING IN A GLOBAL VIRTUAL NETWORK | UMBRA Technologies Ltd. | PATEL, PARTHKUMAR | 2479 | §103 | Non-Final OA | 35d | Pending | Aug 22, 2025 |
| 19041739 | DATA MANAGEMENT SYSTEMS AND METHODS FOR ASSET TOKENIZATION, BLOCKCHAIN-BASED VERIFICATION, AND INTRINSIC VALUATION | Steel American Luxury, LLC | DANG, CHRISTINE | 3698 | §101§103§112 | Final Rejection | — | Pending | Jan 30, 2025 |
| 18754026 | Automated Evaluation of Free-Form Answers and Generation of Actionable Feedback to Multidimensional Reasoning Questions | Brainpop Ip LLC | EGLOFF, PETER RICHARD | 3715 | §101 | Non-Final OA | 23d overdue | Pending | Jun 25, 2024 |
| 18423075 | METHODS FOR IDENTIFYING PROTEIN CODING SEQUENCES USING DNA BARCODES | A-Alpha Bio, Inc. | RAYMONDA, MATTHEW HAROLD | 1684 | §101§103§112 | Non-Final OA | — | Pending | Jan 25, 2024 |
| 18291791 | METHODS FOR IDENTIFYING PROTEIN CODING SEQUENCES USING DNA BARCODES | A-Alpha Bio, Inc. | RAYMONDA, MATTHEW HAROLD | 1684 | §101§103§112 | Non-Final OA | — | Pending | Jan 24, 2024 |
| 18535960 | Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS | Yeda Research And Development Co. Ltd. | OUSPENSKI, ILIA I | 1644 | §112DP | Non-Final OA | — | Pending | Dec 11, 2023 |
| 18374601 | Treatment of Kidney Disease Using Renal Nerve Denervation Via the Renal Pelvis | Verve Medical, Inc. | ZINK, AMANDA L | 3794 | §102§103 | Non-Final OA | — | Pending | Sep 28, 2023 |
| 18143482 | SYSTEMS AND METHODS FOR PROVIDING RECOMMENDATIONS BASED ON COLLABORATIVE AND/OR CONTENT-BASED NODAL INTERRELATIONSHIPS | Nara Logics, Inc. | LEVINE, ADAM L | 3689 | §101§102§103 | Final Rejection | — | Pending | May 04, 2023 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial89.8% of resolved applications prosecuted by Gardella Alciati were allowed, across 404 applications in USPTO records.
2.44 office actions per allowed application on average.
9 pending office actions as of October 2026, for 7 clients, before 8 examiners in 8 art units.
